Tri Chemical Laboratories Inc. (4369) AI Stock Analysis

• Market Cap: ¥91.25B
• Dividend Yield: 1.25%
• Average Volume (3M): 385.53K
• Price to Earnings (P/E): 17.0
• Beta (1Y): 1.24
• Revenue Growth: 96.61%
• EPS Growth: 133.90%
• Country: JP
• Employees: 274
• Sector: Basic Materials
• Sector Strength: 68
• Industry: Chemicals - Specialty
• EPS (TTM): 37.16
• Shares Outstanding: 32,498,640
• 10 Day Avg. Volume: 589,380
• 30 Day Avg. Volume: 385,533
• PEG Ratio: 0.95
• Price to Book (P/B): 8.67
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 336.48
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥3,300.00
• Price Target Upside: 17.52% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 78 Outperform
• Price Target: ¥3,201.00 ▲(14.00%Upside)

Tri Chemical Laboratories Inc. demonstrates strong financial performance with impressive revenue growth and profitability, which is the most significant factor in its score. The technical analysis indicates medium-term bullish momentum, though recent short-term trends are bearish. The valuation is reasonable, providing a moderate income potential, collectively supporting a robust overall stock score.

Tri Chemical Laboratories Inc. Business Overview & Revenue Model

Company Description

Tri Chemical Laboratories Inc. (4369) is a Japanese company specializing in the production and supply of high-purity chemicals primarily for the semiconductor and electronics industries. It operates in sectors focused on the development and manufacturing of advanced materials used in semiconductor fabrication, providing essential products that enable the progression of technology in electronics manufacturing.

How the Company Makes Money

Tri Chemical Laboratories Inc. generates revenue through the sale of high-purity chemicals and materials used in semiconductor manufacturing processes. Its key revenue streams include the production and distribution of these chemicals to semiconductor manufacturers and associated industries. The company may also benefit from strategic partnerships with major electronics firms, leveraging these relationships to enhance its market reach and product offerings. Additionally, any advancements or innovations within the semiconductor industry directly contribute to the demand for Tri Chemical Laboratories' products, impacting its earnings positively.

Tri Chemical Laboratories Inc. Financial Statement Overview

Summary

Tri Chemical Laboratories Inc. exhibits a strong financial position with impressive revenue and profit growth, solid profitability margins, and effective equity utilization. While the cash flow statement shows some challenges in free cash flow growth, the overall financial health remains robust with low leverage and strong operational cash generation.

Income Statement

Tri Chemical Laboratories Inc. shows strong revenue growth with a significant increase from the previous year. The gross profit margin and net profit margin are robust, indicating effective cost management. The company also maintains healthy EBIT and EBITDA margins, reflecting strong operational performance.

Balance Sheet

The company has a solid equity base with a high equity ratio, which suggests financial stability. The debt-to-equity ratio is low, indicating low financial leverage and reduced risk. Return on Equity (ROE) is excellent, showing effective utilization of shareholders' equity.

Cash Flow

Operating cash flow is strong, indicating good cash generation from operations. However, there was a decline in free cash flow growth, signaling potential challenges in managing capital expenditures. The cash flow ratios relative to net income are healthy, reflecting efficient cash management.

Breakdown
Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement		Total Revenue
18.91B	11.25B	13.80B	11.57B	9.80B
	Gross Profit
8.01B	4.09B	5.58B	4.84B	4.38B
	EBIT
5.26B	1.95B	3.50B	2.98B	2.69B
	EBITDA
6.63B	4.61B	7.42B	6.35B	5.17B
	Net Income Common Stockholders
4.96B	2.47B	4.83B	4.10B	3.38B
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
9.44B	10.50B	11.14B	8.03B	1.70B
	Total Assets
36.94B	31.86B	32.12B	28.29B	19.87B
	Total Debt
1.78B	2.40B	3.24B	4.28B	5.05B
	Net Debt
-7.66B	-8.10B	-7.89B	-3.75B	3.35B
	Total Liabilities
5.36B	4.29B	6.24B	6.97B	7.27B
	Stockholders Equity
31.59B	27.57B	25.88B	21.32B	12.60B
Cash Flow		Free Cash Flow
605.75M	1.19B	4.84B	2.71B	-872.24M
	Operating Cash Flow
3.68B	2.97B	6.39B	3.64B	2.09B
	Investing Cash Flow
-3.12B	-1.78B	-1.56B	-932.88M	-2.96B
	Financing Cash Flow
-1.62B	-1.86B	-1.70B	3.59B	948.34M

Tri Chemical Laboratories Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2808.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4369, the sentiment is Positive. The current price of 2808 is below the 20-day moving average (MA) of 2843.35, above the 50-day MA of 2620.72, and below the 200-day MA of 3042.53, indicating a neutral trend. The MACD of 42.70 indicates Positive momentum. The RSI at 62.88 is Neutral, neither overbought nor oversold. The STOCH value of 40.25 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4369.

Tri Chemical Laboratories Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4365	79 Outperform	¥58.73B	7.71		2.20%	5.44%	8.53%
4113	79 Outperform	¥17.74B	12.00		3.55%	4.85%	80.14%
4369	78 Outperform	¥91.25B	17.03		1.25%	96.61%	133.90%
4028	75 Outperform	¥74.08B	8.43		4.58%	4.87%	5.12%
4008	66 Neutral	¥60.54B	9.73		4.56%	3.21%	-1.94%
Sector *	51 Neutral	$2.04B	-1.15	-21.24%	3.95%	2.91%	-30.44%

Tri Chemical Laboratories Inc. Corporate Events

Tri Chemical Laboratories Reports Strong Q1 2025 Financial Growth

Tri Chemical Laboratories Inc. reported significant financial growth for the three months ended April 30, 2025, with net sales doubling and operating profit increasing by 157.6% compared to the previous year. This financial performance indicates a strong market position and potential positive implications for stakeholders, as the company maintains a robust capital adequacy ratio of 80.7% and forecasts continued growth in the fiscal year ending January 31, 2026.

The most recent analyst rating on (JP:4369) stock is a Buy with a Yen5100.00 price target. To see the full list of analyst forecasts on Tri Chemical Laboratories Inc. stock, see the JP:4369 Stock Forecast page.

Tri Chemical Laboratories Explores Joint Ventures in China

Tri Chemical Laboratories Inc. has signed a memorandum of understanding with Hefei ADChem Semi-Tech. Co., Ltd. to explore joint ventures in the Chinese semiconductor market. This collaboration aims to leverage ADChem’s technological capabilities and market presence in China, though it is expected to have minimal impact on Tri Chemical’s performance in the current fiscal year.

The most recent analyst rating on (JP:4369) stock is a Buy with a Yen5100.00 price target. To see the full list of analyst forecasts on Tri Chemical Laboratories Inc. stock, see the JP:4369 Stock Forecast page.

Tri Chemical Laboratories Completes New Semiconductor Materials Plant

Tri Chemical Laboratories Inc. has completed the construction of a new plant in Minami-Alps City, Yamanashi Prefecture, aimed at manufacturing new etching and CVD materials for next-generation semiconductors. The plant, which represents an investment of approximately 12 billion yen, is expected to begin operations in the first half of 2025. This development is part of the company’s strategic expansion to enhance its production capabilities and market positioning in the semiconductor industry.

Tri Chemical Laboratories Reports Strong Financial Growth in FY2025

Tri Chemical Laboratories Inc. reported significant financial growth for the fiscal year ended January 31, 2025, with net sales increasing by 68.1% and operating profit surging by 169.8% compared to the previous year. The company’s strong financial performance underscores its robust market positioning and potential positive implications for stakeholders, as it continues to enhance its profitability and operational efficiency.